Trials / Unknown
UnknownNCT03725865
A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke
A Clinical Study of Intracerebral Transplantation of Human Peripheral Blood Derived Induced Neural Stem Cells for Cerebral Hemorrhagic Stroke
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Allife Medical Science and Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a single centre、single arm、open-label，to investigate the safety and efficacy of induction of neural stem cells transplantation in the brain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Induction of neural stem cells | Brain injection iNSC |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2018-10-31
- Last updated
- 2018-10-31
Source: ClinicalTrials.gov record NCT03725865. Inclusion in this directory is not an endorsement.